Found: 12
Select item for more details and to access through your institution.
A Single Nucleotide Mixture Enhances the Antitumor Activity of Molecular-Targeted Drugs Against Hepatocellular Carcinoma.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.951831
- By:
- Publication type:
- Article
Knockdown of TANK-Binding Kinase 1 Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Molecular-Targeted Drugs.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.924523
- By:
- Publication type:
- Article
A Novel Small-Molecule Inhibitor of SREBP-1 Based on Natural Product Monomers Upregulates the Sensitivity of Lung Squamous Cell Carcinoma Cells to Antitumor Drugs.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.895744
- By:
- Publication type:
- Article
Quantitative examination of the inhibitory activation of molecular targeting agents in hepatocellular carcinoma patient‐derived cell invasion via a novel in vivo tumor model.
- Published in:
- Animal Models & Experimental Medicine, 2019, v. 2, n. 4, p. 259, doi. 10.1002/ame2.12085
- By:
- Publication type:
- Article
Effect of the hyaluronic acid‐poloxamer hydrogel on skin‐wound healing: in vitro and in vivo studies.
- Published in:
- Animal Models & Experimental Medicine, 2019, v. 2, n. 2, p. 107, doi. 10.1002/ame2.12067
- By:
- Publication type:
- Article
Novel nanoparticle CS-C<sub>60</sub>-Fe<sub>3</sub>O<sub>4</sub> magnetically induces tissue-specific aggregation and enhances thermal ablation of hepatocellular carcinoma.
- Published in:
- Cancer Nanotechnology (1868-6958), 2024, v. 15, n. 1, p. 1, doi. 10.1186/s12645-024-00245-7
- By:
- Publication type:
- Article
Novel Nanocrystal Injection of Insoluble Drug Anlotinib and Its Antitumor Effects on Hepatocellular Carcinoma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.777356
- By:
- Publication type:
- Article
Hsa-miR-4277 Decelerates the Metabolism or Clearance of Sorafenib in HCC Cells and Enhances the Sensitivity of HCC Cells to Sorafenib by Targeting cyp3a4.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.735447
- By:
- Publication type:
- Article
FHL1 interacts with oestrogen receptors and regulates breast cancer cell growth.
- Published in:
- Journal of Cellular & Molecular Medicine, 2011, v. 15, n. 1, p. 72, doi. 10.1111/j.1582-4934.2009.00938.x
- By:
- Publication type:
- Article
Combination treatment with FAAH inhibitors/URB597 and ferroptosis inducers significantly decreases the growth and metastasis of renal cell carcinoma cells via the PI3K-AKT signaling pathway.
- Published in:
- Cell Death & Disease, 2023, v. 14, n. 4, p. 1, doi. 10.1038/s41419-023-05779-z
- By:
- Publication type:
- Article
Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells.
- Published in:
- Cell Death & Disease, 2018, v. 9, n. 7, p. 1, doi. 10.1038/s41419-018-0804-6
- By:
- Publication type:
- Article
Incidence of renal cell carcinoma after solid organ transplantation: a systematic review and meta-analysis.
- Published in:
- BMC Urology, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12894-023-01389-1
- By:
- Publication type:
- Article